Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DYAX
351
DELISTED
DYAX CORPORATION
DYAX
| $35.6M | 0.07% |
947,540
+659,811
| +229% | +$21.2M |
|
|
LPNT
352
DELISTED
LifePoint Health, Inc.
LPNT
| $35.6M | 0.07% |
485,269
+393,718
| +430% | +$28M |
|
|
MJN
353
DELISTED
Mead Johnson Nutrition Company
MJN
| $35.5M | 0.07% |
450,058
-1,019,041
| -69% | -$80.3M |
|
354
Helix Energy Solutions
HLX
$1.53B
| $35.5M | 0.07% |
6,744,555
+1,562,562
| +30% | +$9.06M |
|
355
SiriusXM
SIRI
$9.67B
| $35.2M | 0.07% |
865,202
+533,022
| +160% | +$21.5M |
|
356
MGM Resorts International
MGM
$11B
| $35.1M | 0.07% |
1,547,033
-19,529
| -1% | -$431K |
|
|
VMW
357
DELISTED
VMware, Inc
VMW
| $35M | 0.07% |
618,770
-88,724
| -13% | -$5.52M |
|
|
GGP
358
DELISTED
GGP Inc.
GGP
| $34.9M | 0.07% |
1,284,027
-1,899,496
| -60% | -$51.1M |
|
359
United Therapeutics
UTHR
$22B
| $34.9M | 0.07% |
222,888
+6,792
| +3% | +$989K |
|
360
Capital One
COF
$134B
| $34.9M | 0.07% |
483,515
+103,962
| +27% | +$7.96M |
|
361
OGE Energy
OGE
$9.42B
| $34.8M | 0.07% |
1,324,075
+1,036,878
| +361% | +$27.8M |
|
|
DPLO
362
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $34.8M | 0.07% |
1,016,467
+834,628
| +459% | +$26M |
|
|
SCHW
363
Charles Schwab
SCHW
$194B
| $34.7M | 0.07% |
1,055,147
+1,031,159
| +4,299% | +$32.6M |
|
364
Watsco Inc
WSO
$12.9B
| $34.7M | 0.07% |
296,411
+80,119
| +37% | +$9.88M |
|
365
Toronto Dominion Bank
TD
$194B
| $34.6M | 0.07% |
883,370
+807,415
| +1,063% | +$32.7M |
|
|
PRXL
366
DELISTED
Parexel International Corp
PRXL
| $34.6M | 0.07% |
507,916
+472,202
| +1,322% | +$30.7M |
|
367
Costco
COST
$420B
| $34.6M | 0.07% |
214,119
+207,617
| +3,193% | +$32.8M |
|
|
SYNH
368
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $34.6M | 0.07% |
712,675
+309,034
| +77% | +$13.7M |
|
|
ACAS
369
DELISTED
American Capital Ltd
ACAS
| $34.5M | 0.07% |
2,501,912
+1,067,715
| +74% | +$14.6M |
|
|
HOUS
370
DELISTED
Anywhere Real Estate
HOUS
| $34.4M | 0.07% |
939,207
+210,324
| +29% | +$8.31M |
|
371
Charles River Laboratories
CRL
$14.1B
| $34.4M | 0.07% |
428,289
+107,847
| +34% | +$7.78M |
|
372
Take-Two Interactive
TTWO
$44.8B
| $34.4M | 0.07% |
988,108
-419,019
| -30% | -$14.1M |
|
373
Entergy
ETR
$48.8B
| $34.3M | 0.07% |
1,003,204
-657,092
| -40% | -$22.1M |
|
|
XLRN
374
DELISTED
Acceleron Pharma
XLRN
| $34.2M | 0.07% |
702,177
+553,484
| +372% | +$19.9M |
|
375
Post Holdings
POST
$3.65B
| $34M | 0.07% |
841,922
+628,434
| +294% | +$26M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.